About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 431 record(s)
Req # A-2021-000672
Adverse Drug Reaction (ADR) for PREDNISOLONE SODIUM PHOSPHATE. Report number: E2B_03278670.Organization: Health Canada
August 2021
Req # A-2021-000675
Adverse Reaction Reports (AERs) for DUPILUMAB. Report numbers: E2B_03467962, E2B_03417694.Organization: Health Canada
August 2021
Req # A-2021-000676
Adverse Drug Reaction (ADR) for CYTARABINE. Report number: 919319.Organization: Health Canada
August 2021
Req # A-2021-000690
Adverse Drug Reaction (ADR). Report number: 000941436.Organization: Health Canada
August 2021
Req # A-2021-000691
Adverse Drug Reaction (ADR) for Scopolamine. Report number: 000932168.Organization: Health Canada
August 2021
Req # A-2021-000701
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116197-660, Interim Order for Medical Devices - Performance.Organization: Health Canada
August 2021
Req # A-2021-000705
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109078-620, Management of COVID-19 Medical Devices applications.Organization: Health Canada
August 2021
Req # A-2021-000706
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-108121-589, MDAP (Medical Devices Action Plan) Progress Report.Organization: Health Canada
August 2021
Req # A-2021-000722
Adverse Drug Reaction (ADR). Report number: 000945499.Organization: Health Canada
August 2021
Req # A-2021-000725
All records describing the isolation of a SARS-COV-2 virus, directly from a sample taken from a diseased patient, where the patient sample was not first combined with any other source of genetic material (i.e.monkey kidney cells aka Vero cells; liver cancer cells). Please note that I am using "isolation" in the every-day sense of the word: the act of separating a thing(s) from everything else. I am not requesting records where "isolation of SARS-COV-2" refers instead to: the culturing of something, or the performance of an amplification test (i.e. a PCR test), or the sequencing of something. To clarify, I am requesting all such records that are in the possession, custody or control of Health Canada.Organization: Health Canada
August 2021